Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-2 of 2

Sort by

Sort Order Select

Journal Articles

CFT8634, a Clinical Stage BRD9 Bi DAC™ Degrader, Is Active in a Subset of Multiple Myeloma Cell Line Models and Synergistic When Combined with Pomalidomide

Laura L Poling, David Cocozziello, Minsheng He, Eunju Hurh, Riadh Lobbardi, Katrina L Jackson, Stewart L Fisher, Roy M Pollock

Blood (2023) 142 (Supplement 1): 6594.

https://doi.org/10.1182/blood-2023-174555

Published: 2023

Journal Articles

CFT7455, a Novel IKZF1/3 Degrader, Demonstrates Potent Anti-Tumor Activity in Models of Non-Hodgkin's Lymphoma As a Single Agent or in Combination with Clinically Approved Agents

Samantha Perino, R. Jason Kirby, Roman Agafonov, Prasoon Chaturvedi, Scott Eron, Andrew Good, Ashley Hart, Minsheng He, Riadh Lobbardi, Andrew J Phillips, David Proia, James Henderson, Michael Thomeius, Christopher Nasveschuk, Stewart L Fisher, Roy Macfarlane Pollock

Blood (2022) 140 (Supplement 1): 11575.

https://doi.org/10.1182/blood-2022-166541

Published: 2022